Claims
- 1. A compound of the formula (I): ##STR22## or a pharmaceutically acceptable salt thereof, wherein X is oxygen or sulphur, Y is oxygen, one of R.sub.1 and R.sub.2 is hydrogen and the other is selected from the group consisting of alkylcarbonyloxy of 1 to 6 carbon atoms in the alkyl moiety, nitro, cyano, chloro, trifluoromethyl, alkylsulphinyl of 1 to 6 carbon atoms in the alkyl moiety, alkylsulphonyl of 1 to 6 carbon atoms in the alkyl moiety, alkoxysulphinyl of 1 to 6 carbon atoms in the alkoxy moiety, alkoxysulphonyl of 1 to 6 carbon atoms in the alkoxy moiety, alkylcarbonylamino of 1 to 6 carbon atoms in the alkyl moiety, alkoxycarbonylamino of 1 to 6 carbon atoms in the alkoxy moiety, alkylthiocarbonyl of 1 to 6 carbon atoms in the alkyl moiety, alkoxythiocarbonyl of 1 to 6 carbon atoms in the alkoxy moiety, alkylthiocarbonyloxy of 1 to 6 carbon atoms in the alkyl moiety, 1-mercaptoalkyl of 2 to 7 carbon atoms in the alkyl moiety, formyl, aminosulphinyl, aminosulphonyl and aminocarbonyl, wherein the amino moiety is unsubstituted or substituted by one or two alkyl moieties of 1 to 6 carbon atoms, or the other of Rl and R2 is alkylsulphinylamino of 1 to 6 carbon atoms in the alkyl moiety, alkylsulphonylamino of 1 to 6 carbon atoms in the alkyl moiety, alkoxysulphinylamino of 1 to 6 carbon atoms in the alkoxy moiety, alkoxysulphonylamino of 1 to 6 carbon atoms in the alkoxy moiety or ethenyl terminally substituted by alkylcarbonyl of 1 to 6 carbon atoms in the alkyl moiety, nitro or cyano; or one of R.sub.1 and R.sub.2 is nitro, cyano or alkylcarbonyl of 1 to 3 carbon atoms and the other is methoxy or amino unsubstituted or substituted by alkanoyl or 2 to 7 carbon atoms in the alkyl moiety; one of R.sub.3 and R.sub.4 is hydrogen or alkyl of 1 to 4 carbon atoms and the other is alkyl of 1 to 4 carbon atoms, or R.sub.3 and R.sub.4 together are polymethylene of 2 to 5 carbon atoms; R.sub.5 is hydroxy, alkoxy of of 1 to 6 carbon atoms or unsubstituted aliphatic acyloxy; R.sub.6 is hydrogen or alkyl of of 1 to 6 carbon atoms; R.sub.7 is NR.sub.8 R.sub.9 wherein R.sub.8 and R.sub.9 are each alkyl of of 1 to 6 carbon atoms; or R.sub.8 is hydrogen and R.sub.9 is alkyl of 1 to 6 carbon atoms; or R.sub.8 and R.sub.9 together are polymethylene of 4 or 5 carbon atoms; or R.sub.6 and R.sub.8 together are --(CH.sub.2).sub.n -- wherein n is 2 or 3, and R.sub.9 is hydrogen or alkyl of of I to 6 carbon atoms; or R.sub.7 is CH.sub.2 R.sub.10 wherein R.sub.10 is hydrogen or alkyl of 1 to 5 carbon atoms; or R.sub.6 and R.sub.10 are --(CH.sub.2).sub.m -- wherin m is 2 or 3, the R.sub.6 --CH--CX--R.sub.7 moiety being trans to the R.sub.5 moiety.
- 2. A compound according to claim 1 of the formula (II): ##STR23## wherein R.sub.1.sup.1 is nitro, cyano, CF.sub.3 or alkylcarbonyl of 1 to 6 carbon atoms in the alkyl moiety; R.sub.8.sup.1 and R.sub.9.sup.1 are each alkyl of 1 to 6 carbon atoms; and R.sub.5 is hydroxy, alkoxy of 1 to 6 carbon atoms or unsubstituted aliphatic acyloxy.
- 3. A compound according to claim 1 of the formula (IV): ##STR24## wherein R.sub.7.sup.1 is alkyl of 1 to 6 carbon atoms, R.sub.1.sup.1 is nitro, cyano, CF.sub.3 or alkylcarbonyl of 1 to 6 carbon atoms in the alkyl moiety and R.sub.5 is hydroxy.
- 4. A pharmaceutical composition useful for treating hypertension in mammals including humans which comprises an antihypertensively effective amount of a compound of the formula (I): ##STR25## or a pharmaceutically acceptable salt thereof, wherein X is oxygen or sulphur, Y is oxygen, one of R.sub.1 and R.sub.2 is hydrogen and the other is selected from the group consisting of alkylcarbonyloxy of 1 to 6 carbon atoms in the alkyl moiety, nitro, cyano, chloro, trifluoromethyl, alkylsulphinyl of 1 to 6 carbon atoms in the alkyl moiety, alkylsulphonyl of 1 to 6 carbon atoms in the alkyl moiety, alkoxysulphinyl of 1 to 6 carbon atoms in the alkoxy moiety, alkoxysulphonyl of 1 to 6 carbon atoms in the alkoxy moiety, alkylcarbonylamino of 1 to 6 carbon atoms in the alkyl moiety, alkoxycarbonylamino of 1 to 6 carbon atoms in the alkoxy moiety, alkylthiocarbonyl of 1 to 6 carbon atoms in the alkyl moiety, alkoxythiocarbonyl of 1 to 6 carbon atoms in the alkoxy moiety, alkylthiocarbonyloxy of 1 to 6 carbon atoms in the alkyl moiety, 1-mercaptoalkyl of 2 to 7 carbon atoms in the alkyl moiety, formyl, aminosulphinyl, aminosulphonyl aminocarbonyl, wherein the amino moiety is unsubstituted or substituted by one or two alkyl moieties of 1 to 6 carbon atoms, or the other of R.sub.1 and R.sub.2 is alkylsuphinylamino of 1 to 6 carbon atoms in the alkyl moiety, alkylsulphonylamino of 1 to 6 carbon atoms in the alkyl moiety, alkoxysulphinylamino of 1 to 6 carbon atoms in the alkoxy moiety, alkoxysulphonylamino of 1 to 6 carbon atoms in the alkoxy moiety or ethenyl terminally substituted by alkylcarbonyl of 1 to 6 carbon atoms in the alkyl moiety, nitro or cyano; or one of R.sub.1 and R.sub.2 is nitro, cyano or alkylcarbonyl of 1 to 3 carbon atoms and the other is methoxy or amino unsubstituted or substituted by alkanoyl or 2 to 7 carbon atoms in the alkyl moiety; one of R.sub.3 and R.sub.4 is hydrogen or alkyl of 1 to 4 carbon atoms and the other is alkyl of 1 to 4 carbon atoms, or R.sub.3 and R.sub.4 together are polymethylene of 2 to 5 carbon atoms; R.sub.5 is hydroxy, alkoxy of 1 to 6 carbon atoms or unsubstituted aliphatic acyloxy; R.sub.6 is hydrogen or alkyl of 1 to 6 carbon atoms; R.sub.7 is NR.sub.8 R.sub.9 wherein R.sub.8 and R.sub.9 are each alkyl of 1 to 6 carbon atoms; or R.sub.8 is hydrogen and R.sub.9 is alkyl of 1 to 6 carbon atoms; or R.sub.8 and R.sub.9 together are polymethylene of 4 or 5 carbon atoms; or R.sub.6 and R.sub.8 together are --(CH.sub.2).sub.n -- wherein n is 2 or 3, and R.sub.9 is hydrogen or alkyl of 1 to 6 carbon atoms; or R.sub.7 is CH.sub.2 R.sub.10 wherein R.sub. 10 is hydrogen or alkyl of 1 to 5 carbon atoms; or R.sub.6 and R.sub.10 are --(CH.sub.2).sub.m -- wherein m is 2 or 3, the R.sub.6 --CH--CX--R.sub.7 moiety being trans to the R.sub.5 moiety, in combination with a pharmaceutically acceptable carrier.
- 5. A composition according to claim 4 wherein the compound is of the formula (II): ##STR26## wherein R.sub.1.sup.1 is nitro, cyano, CF.sub.3 or alkylcarbonyl of 1 to 6 carbon atoms in the alkyl moiety; R.sub.8.sup.1 and R.sub.9.sup.1 are each alkyl of 1 to 6 carbon atoms; and R.sub.5 is hydroxy, alkoxy of 1 to 6 carbon atoms or unsubstituted aliphatic acyloxy.
- 6. A composition according to claim 4 wherein the compound is of the formula (IV): ##STR27## wherein R.sub.7.sup.1 is alkyl of 1 to 6 carbon atoms, R.sub.1.sup.1 is nitro, cyano, CF.sub.3 or alkylcarbonyl of 1 to 6 carbon atoms in the alkyl moiety and R.sub.5 is hydroxy.
- 7. A composition according to claim 4 wherein the compound is trans-6-cyano-3,4-dihydro-2,2-dimethyl-4-[N,N-dimethyl-2-acetamido]-2H-1-benzopyran-3-ol.
- 8. A method of treating hypertension in mammals including humans which comprises administering to such a mammal in need thereof in antihypertensively amount of a compound of the formula (I): ##STR28## or a pharmaceutically acceptable salt thereof, wherein X is oxygen or sulphur, Y is oxygen, one of R.sub.1 and R.sub.2 is hydrogen and the other is selected from the group consisting of alkylcarbonyloxy of 1 to 6 carbon atoms in the alkyl moiety, nitro, cyano, chloro, trifluoromethyl, alkylsulphinyl of 1 to 6 carbon atoms in the alkyl moiety, alkylsulphonyl of 1 to 6 carbon atoms in the alkyl moiety, alkoxysulphinyl of 1 to 6 carbon atoms in the alkoxy moiety, alkoxysulphonyl of 1 to 6 carbon atoms in the alkoxy moiety, alkylcarbonylamino of 1 to 6 carbon atoms in the alkyl moiety, alkoxycarbonylamino of 1 to 6 carbon atoms in the alkoxy moiety, alkylthiocarbonyl of 1 to 6 carbon atoms in the alkyl moiety, alkoxythiocarbonyl of 1 to 6 carbon atoms in the alkoxy moiety, alkylthiocarbonyloxy of 1 to 6 carbon atoms in the alkyl moiety, 1-mercaptoalkyl of 2 to 7 carbon atoms in the alkyl moiety, formyl, aminosulphinyl, aminosulphonyl and aminocarbonyl, wherein the amino moiety is unsubstituted or substituted by one or two alkyl moieties of 1 to 6 carbon atoms, or the other of R.sub.1 and R.sub.2 is alkylsulphinylamino of 1 to 6 carbon atoms in the alkyl moiety, alkylsulphonylamino of 1 to 6 carbon atoms in the alkyl moiety, alkoxysulphinylamino of 1 to 6 carbon atoms in the alkoxy moiety, alkoxysulphonylamino of 1 to 6 carbon atoms in the alkoxy moiety or ethenyl terminally substituted by alkylcarbonyl of 1 to 6 carbon atoms in the alkyl moiety, nitro or cyano; or one of R.sub.1 and R.sub.2 is nitro, cyano or alkylcarbonyl of 1 to 3 carbon atoms and the other is methoxy or amino unsubstituted or substituted by alkanoyl or 2 to 7 carbon atoms in the alkyl moiety; one of R.sub.3 and R.sub.4 is hydrogen or alkyl of 1 to 4 carbon atoms and the other is alkyl of 1 to 4 carbon atoms, or R.sub.3 and R.sub.4 together are polymethylene of 2 to 5 carbon atoms; R.sub.5 is hydroxy, alkoxy of 1 to 6 carbon atoms or unsubstituted aliphatic acyloxy; R.sub.6 is hydrogen or alkyl of 1 to 6 carbon atoms; R.sub.7 is NR.sub.8 R.sub.9 wherein R.sub.8 and R.sub.9 are each alkyl of 1 to 6 carbon atoms; or R.sub.8 is hydrogen and R.sub.9 is alkyl of 1 to 6 carbon atoms; or R.sub.8 and R.sub.9 together are polymethylene of 4 or 5 carbon atoms; or R.sub.6 and R.sub.8 together are --(CH.sub.2).sub.n -- wherein n is 2 or 3, and R.sub.9 is hydrogen or alkyl of 1 to 6 carbon atoms; or R.sub.7 is CH.sub.2 R.sub.10 wherein R.sub.10 is hydrogen or alkyl of 1 to 5 carbon atoms; or R.sub.6 and R.sub.10 are --(CH.sub.2).sub.m -- wherein m is 2 or 3, the R.sub.6 --CH--CX--R.sub.7 moiety being trans to the R.sub.5 moiety, in combination with a pharmaceutically acceptable carrier.
- 9. A method according to claim 8 wherein the compound is of the formula (II): ##STR29## wherein R.sub.1.sup.1 is nitro, cyano, CF.sub.3 or alkylcarbonyl of 1 to 6 carbon atoms in the alkyl moiety; R.sub.8.sup.1 and R.sub.9.sup.1 are each alkyl of 1 to 6 carbon atoms; and R.sub.5 is hydroxy, alkoxy of 1 to 6 carbon atoms or unsubstituted aliphatic acyloxy.
- 10. A method according to claim 8 wherein the compound is of the formula (IV): ##STR30## wherein R.sub.7.sup.1 is alkyl of 1 to 6 carbon atoms, R.sub.1.sup.1 is nitro, cyano, CF.sub.3 or alkylcarbonyl of 1 to 6 carbon atoms in the alkyl moiety and R.sub.5 is hydroxy.
- 11. A method according to claim 8 wherein the compound is trans-6-cyano-3,4-dihydro-2,2-dimethyl-4-[N,N-dimethyl-2-acetamido]-2H-1-benzopyran-3-ol.
- 12. A compound selected from the group consisting of trans-6-cyano-3,4-dihydro-2,2-dimethyl-4-[N,N-dimethyl-2-acetamido]-2H-1-benzopyran-3-ol,
- 3,4-dihydro-2,-dimethyl-3-hydroxy-4-[2-oxo-2-(1-piperidinyl)ethyl]-2H-1-benzopyran-6-carbonitrile,
- 6-cyano-3,4-dihydro-3-hydroxy-N-methyl-2,2-dimethyl-2H-1-benzopyran-4-acetamide,
- trans-6-cyano-3,4-dihydro-2,2-dimethyl-4-acetonyl-2H-benzopyran-3-ol and trans-6-aminocarbonyl-3,4-dihydro-2,2-dimethyl-4-acetonyl-2H-1-benzopyran-3-ol.
- 13. A composition according to claim 4 wherein the compound is selected from the group consisting of trans-6-cyano-3,4-dihydro-2,2-dimethyl-4-[N,N-dimethyl-2-acetamido]-2H-1-benzopyran-3-ol,
- 3,4-dihydro-2,-dimethyl-3-hydroxy-4-[2-oxo-2-(1-piperidinyl)ethyl]-2H-1-benzopyran-6-carbonitrile,
- 6-cyano-3,4-dihydro-3-hydroxy-N-methyl-2,2-dimethyl-2H-1-benzopyran-4-acetamide,
- trans-6-cyano-3,4-dihydro-2,2-dimethyl-4-acetonyl-2H-benzopyran-3-ol and
- trans-6-aminocarbonyl-3,4-dihydro-2,2-dimethyl-4-acetonyl-2H-1-benzopyran-3-ol.
- 14. A method according to claim 8 wherein the compound is selected from the group consisting of trans-6-cyano-3,4-dihydro2,2-dimethyl-4-[N,N-dimethyl-2-acetamido]-2H-1-benzopyran-3-ol,
- 3,4-dihydro-2,-dimethyl-3-hydroxy-4-[2-oxo-2-(1-piperidinyl)ethyl]-2H-1-benzopyran-6-carbonitrile,
- 6-cyano-3,4-dihydro-3-hydroxy-N-methyl-2,2-dimethyl-2H-1-benzopyran-4-acetamide,
- trans-6-cyano-3,4-dihydro-2,2-dimethyl-4-acetonyl-2H-benzopyran-3-ol and
- trans-6-aminocarbonyl-3,4-dihydro-2,2-dimethyl-4-acetonyl-2H-1-benzopyran-3-ol.
- 15. The compound 6-cyano-3,4-dihydro-3-hydroxy-N-methyl-N-4-methoxy-benzyl)-2,2-dimethyl-2H-1-benzopyran-4-acetamide.
- 16. The compound trans-6-cyano-3,4-dihydro-2,2-dimethyl-4-[N,N-dimethyl-2-acetamido]-2H-1-benzopyran-3-ol.
Priority Claims (2)
Number |
Date |
Country |
Kind |
8522492 |
Sep 1985 |
GBX |
|
8523051 |
Sep 1985 |
GBX |
|
Parent Case Info
This is a continuation application of Ser. No. 905,695, filed Sept. 9, 1986, now abandoned.
US Referenced Citations (7)
Foreign Referenced Citations (1)
Number |
Date |
Country |
0076075 |
Apr 1983 |
EPX |
Non-Patent Literature Citations (1)
Entry |
Bhattacharya, et al., C.A.:103:123289d (1985). |
Continuations (1)
|
Number |
Date |
Country |
Parent |
905695 |
Sep 1986 |
|